Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer
The addition of dimethyldiguanide might increase the efficacy of AI treatment in metastatic breast cancer.
Metastatic Breast Cancer
DRUG: AI plus Dimethyldiguanide|DRUG: Aromatase Inhibitor
progression free survival, 9 months
The addition of dimethyldiguanide might increase the efficacy of AI in patients with metastatic breast cancer after the failure of the first line endocrine therapy.